# Pharmacist-led SABA overuse case-finding combined with FeNO supported management of high-risk symptomatic patients with asthma: a pilot study

Source: [Medical research : nature.com subject feeds](https://www.nature.com/articles/s41533-026-00583-6) · 2026-11-20 · Medicine
Page: https://themorning.science/story/pharmacist-led-saba-overuse-case-finding-combined-with-feno-supported-management-b58a6dd41b8f4481
Kind: research · Impact: low

## In brief

- A pilot study examined pharmacist-led case-finding for short-acting beta-agonist (SABA) overuse in asthma.
- The approach was combined with fractional exhaled nitric oxide (FeNO) testing to support management of high-risk symptomatic patients.
- The study was listed in the nature.com subject feed dated 2026-11-20; the available source provides no summary of results.

## Why it matters

It describes a possible way to identify asthma patients who overuse reliever inhalers and to support their management, but as a pilot study its effectiveness is not established.

## Timeline

- 2026-11-20: Pilot study appeared in nature.com subject feed

## Coverage

- [Pharmacist-led SABA overuse case-finding combined with FeNO supported management of high-risk symptomatic patients with asthma: a pilot study](https://www.nature.com/articles/s41533-026-00583-6) — Medical research : nature.com subject feeds, 2026-11-20

Tags: asthma, pharmacy, saba, feno, respiratory medicine

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
